Clinical Trial Record

Return to Clinical Trials

RCT of Mobile Apps & FitBit v. Usual Care


2017-05-31


2025-08


2025-08


107

Study Overview

RCT of Mobile Apps & FitBit v. Usual Care

This is a randomized clinical trial to evaluate the use of mobile devices in preventing readmission in patients undergoing major GI cancer operations.

Patients will be randomized to 1) standard of care or 2) to use our mobile app with standard care. The mobile app will collect information on patients' daily physical activity patterns and health status data for clinicians using smartphone mobile technology applications. The investigators believe that by tracking information on patients, the investigators may be able to intervene sooner and prevent a delay in care.

  • Pancreatic Cancer
  • Gastric Cancer
  • Hepatic Cancer
  • Colon Cancer
  • Rectal Cancer
  • Small Bowel Cancer
  • OTHER: Mobile health application and Fitbit + standard of care
  • OTHER: Standard of care
  • 1608017482

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2017-04-24  

N/A  

2025-03-11  

2018-08-06  

N/A  

2025-03-14  

2018-08-09  

N/A  

2025-03  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Other


Allocation:
Randomized


Interventional Model:
Parallel


Masking:
None


Arms and Interventions

Participant Group/ArmIntervention/Treatment
ACTIVE_COMPARATOR: Mobile app and Fitbit + Standard of care

Mobile health application and Fitbit + standard of care: Participants will utilize mobile app and Fitbit and standard of care. Mobility data will be generated using a mobile health tracker designed for smartphone devices.

OTHER: Mobile health application and Fitbit + standard of care

  • Mobility data will be generated using a mobile health tracker designed for smartphone devices, which allows the phone to automatically and passively (no patient input needed) capture information on the patient's activity; i.e. if the person is walkin
OTHER: Standard of care

Participants will receive standard of care

OTHER: Mobile health application and Fitbit + standard of care

  • Mobility data will be generated using a mobile health tracker designed for smartphone devices, which allows the phone to automatically and passively (no patient input needed) capture information on the patient's activity; i.e. if the person is walkin

OTHER: Standard of care

  • Post-operative standard of care information
Primary Outcome MeasuresMeasure DescriptionTime Frame
Readmission rateInvestigators will track readmission rates after surgery for those on the trial30 days
Secondary Outcome MeasuresMeasure DescriptionTime Frame
Healthcare utilization ratesInvestigators will track patients' healthcare resource utilization and the cost of this utilization by assessing how often the patients contact their providers via phone or the app, access the emergency room, and through readmission data.30 days
Patient Satisfaction with DeviceInvestigators will assess patients' satisfaction with their care experience and device. This will be done with an internal questionnaire asking if patients were satisfied and if they found it easy to use.30 days
Quality of life: Return to Baseline Function-WalkingInvestigators will monitor patients' return to baseline health after surgery by tracking progress via step counts, as monitored by a FitBit tracker.30 days
Quality of life: Return to Baseline Function-Activities of Daily Living (ADLs)Investigators will monitor patients' return to baseline health after surgery by tracking progress using a questionnaire, modified from the Katz Activities of Daily Living scale. For this scale, a score of 6 is high, indicating that the patient is independent and a score of 0 is low, indicating that the patient very dependent in performing their ADLs.30 days

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:
    1. Subject is 18 years or older 2. Subject speaks English 3. Subject owns a smart phone 4. Subject is scheduled to undergo surgery for a GI cancer (pancreatic, hepatic, gastric, small bowel, colon, or rectal cancers)
    Exclusion Criteria:
    1. Physician deems the subject is unable to complete the study due to documented dementia 2. Subject is undergoing emergent surgery 3. Subject has sepsis from another source 4. Physician deems the subject is unable to complete the study due to documented alcohol and/or drug abuse

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

  • Damon Runyon Cancer Research Foundation

  • PRINCIPAL_INVESTIGATOR: Heather Yeo, MD, Weill Medical College of Cornell University

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available